Mitral Regurgitation and Serum N-Terminal Pro-Brain Natriuretic Peptide Levels in Children: A Modification of Adult

Elif Erolu1, Figen Akalin2

  • 1Division of Pediatric Cardiology, Department of Pediatrics, University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Istanbul, Turkey.

Insights

Serum NT-proBNP levels correlate with mitral regurgitation severity in children, suggesting adult echocardiographic parameters are applicable for pediatric surgical decisions. This study validates NT-proBNP as a biomarker for assessing mitral regurgitation in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Biomarkers
  • Echocardiography

Background:

  • Mitral regurgitation (MR) in children necessitates surgical intervention, but adult assessment criteria may not apply.
  • Evaluating MR severity and guiding surgical decisions in pediatric patients requires validated methods.

Purpose of the Study:

  • To investigate the correlation between echocardiographic parameters and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in children with chronic mitral regurgitation.
  • To determine if adult echocardiographic criteria can be reliably used for pediatric MR assessment and surgical decision-making.

Main Methods:

  • Echocardiographic measurements (M-mode, volumes, Doppler) and serum NT-proBNP levels were collected from 45 pediatric patients with MR and 38 healthy controls.
  • Mitral regurgitation was graded using European Association of Echocardiography recommendations; key parameters were indexed to body surface area.
  • Patients were stratified by MR severity (mild vs. moderate/severe) and left ventricular size (normal vs. enlarged).

Main Results:

  • Serum NT-proBNP levels were significantly higher in pediatric patients with MR compared to controls (P=0.003).
  • Elevated NT-proBNP levels correlated with MR severity, enlarged left ventricle, and specific echocardiographic parameters including effective regurgitant area, vena contracta, regurgitant volume, left ventricular end-systolic diameter, and left atrial diameter.
  • An NT-proBNP cutoff of 66 pg/mL effectively distinguished mild MR from moderate/severe MR.

Conclusions:

  • Serum NT-proBNP levels are a valuable biomarker for assessing mitral regurgitation severity in children.
  • Indexed echocardiographic parameters and NT-proBNP levels, validated in adults, can be effectively applied to pediatric patients for grading MR and informing surgical management.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
74
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
42
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
38
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
31
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195